Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01349205 · ClinicalTrials.gov registry record · NA
Caffeine in Children With Obstructive Sleep Apnea, Dose Response Study
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT01349205 is a NA study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 42 participants.
The verdict
NCT01349205, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The aim of this study is to evaluate whether a smaller dose of caffeine sodium benzoate 10 mg/kg IV is as effective as 20 mg/kg IV in decreasing the number of children who develop post extubation adverse upper airway respiratory events compared to placebo.
Interventions
- DRUG Caffeine and sodium Benzoate 10 mg/kg IV
- DRUG Caffeine and Sodium Benzoate 20 mg/kg IV
- DRUG 0.9 NS Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2010-03 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01349205
The ClinicalTrials.gov registry entry for NCT01349205 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Caffeine and sodium Benzoate 10 mg/kg IV is the first listed.
NCT01349205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01349205 about?
NCT01349205 is a clinical study titled "Caffeine in Children With Obstructive Sleep Apnea, Dose Response Study". The aim of this study is to evaluate whether a smaller dose of caffeine sodium benzoate 10 mg/kg IV is as effective as 20 mg/kg IV in decreasing the number of children who develop post extubation adverse upper airway respiratory events compared to placebo.
What is the current status of trial NCT01349205?
This trial is currently terminated. It is a NA study. The enrollment target is 42 participants. The study started on 2010-03. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01349205?
The interventions under investigation include: Caffeine and sodium Benzoate 10 mg/kg IV (DRUG), Caffeine and Sodium Benzoate 20 mg/kg IV (DRUG), 0.9 NS Saline (DRUG).
Who is sponsoring clinical trial NCT01349205?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.